206 related articles for article (PubMed ID: 3461685)
1. Aclarubicin in the treatment of elderly patients with acute nonlymphocytic leukemia.
Takahashi I; Yorimitsu S; Hara M; Inagaki T; Nakada H; Sekito N; Hayashi N; Nonaka K; Ohmoto E; Uchida K
Acta Med Okayama; 1986 Jun; 40(3):175-7. PubMed ID: 3461685
[TBL] [Abstract][Full Text] [Related]
2. [Studies on hematological diseases in elderly patients. Part 4: Chemotherapeutic effect of aclarubicin (ACR) on acute nonlymphocytic leukemia in the aged].
Yorimitsu S; Takahashi I; Lai M; Ohmoto E; Aoyama S; Inagaki T; Ueda I; Nishimura M; Nakada H; Nonaka K
Nihon Ronen Igakkai Zasshi; 1986 May; 23(3):302-8. PubMed ID: 3463814
[No Abstract] [Full Text] [Related]
3. Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial.
Pedersen-Bjergaard J; Brincker H; Ellegaard J; Drivsholm A; Freund L; Jensen KB; Jensen MK; Nissen NI
Cancer Treat Rep; 1984 Oct; 68(10):1233-8. PubMed ID: 6597002
[TBL] [Abstract][Full Text] [Related]
4. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
[TBL] [Abstract][Full Text] [Related]
5. Treatment of relapsed acute myelocytic leukemia with a combination of aclarubicin and cytosine arabinoside.
Takahashi I; Hara M; Uchida K; Takaoka K; Watanabe S; Lai M; Hamasaki K; Kohi F; Kitajima K; Kimura I; Adachi T; Yorimitsu S; Tokioka M; Sanada H
Acta Med Okayama; 1982 Feb; 36(1):77-80. PubMed ID: 6950658
[TBL] [Abstract][Full Text] [Related]
6. Aclarubicin (aclacinomycin A) in the treatment of relapsing acute leukaemias.
Mitrou PS; Kuse R; Anger H; Herrmann R; Bonfert B; Pralle H; Thiel E; Westerhausen M; Mainzer K; Bartels H
Eur J Cancer Clin Oncol; 1985 Aug; 21(8):919-23. PubMed ID: 3862584
[TBL] [Abstract][Full Text] [Related]
7. Aclarubicin-associated QTc prolongation and ventricular fibrillation.
Iwata N; Karasawa M; Omine M; Maekawa T; Suzuki T; Kawai Y
Cancer Treat Rep; 1984 Mar; 68(3):527-9. PubMed ID: 6584207
[TBL] [Abstract][Full Text] [Related]
8. Phase I-II study of aclarubicin for treatment of acute myeloid leukemia.
Machover D; Gastiaburu J; Delgado M; Goldschmidt E; Hulhoven R; Misset JL; de Vassal F; Tapiero H; Ribaud P; Schwarzenberg L
Cancer Treat Rep; 1984 Jun; 68(6):881-6. PubMed ID: 6587933
[TBL] [Abstract][Full Text] [Related]
9. Phase II evaluation of aclarubicin in refractory adult acute leukemia: a Southwest Oncology Group Study.
Dabich L; Bull FE; Beltran G; Athens JW; Coltman CA; Weick JK; Van Slyck EJ; Amare M
Cancer Treat Rep; 1986 Aug; 70(8):967-9. PubMed ID: 3460700
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of aclarubicin in acute myeloblastic leukemia.
Case DC; Ervin TJ; Boyd MA; Bove LG; Sonneborn HL; Paul SD
Am J Clin Oncol; 1987 Dec; 10(6):523-6. PubMed ID: 3479891
[TBL] [Abstract][Full Text] [Related]
11. Phase I-II study of aclarubicin for treatment of acute myeloid leukaemia.
Machover D; Gastiaburu J; Delgado M; Goldschmidt E; Hulhoven R; Benavides M; Lotz JP; Misset JL; de Vassal F; Tapiero H
Eur J Haematol Suppl; 1987; 47():33-42. PubMed ID: 3471523
[No Abstract] [Full Text] [Related]
12. Aclarubicin in the treatment of relapsed or resistant acute myelogenous leukaemia: a phase II trial.
Evensen SA; Wisløff F; Müller E; Talstad I; Waage A; Johansen L
Eur J Haematol Suppl; 1987; 47():43-7. PubMed ID: 3471524
[No Abstract] [Full Text] [Related]
13. [Combination chemotherapy of N(4)-behenoyl-1-beta-arabinofuranosylcytosine, aclarubicin, 6-MP, and prednisolone (BH-AC. AMP therapy) for adult acute non-lymphocytic leukemia].
Ishige K; Takagi T; Oguro M
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1475-9. PubMed ID: 6588925
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of acute nonlymphocytic leukemia in children].
Tawa A; Kawa K; Ikeda T; Okuni H; Okubo Y; Masaoka T; Nishida M; Nishikawa A; Yoshioka K; Yoshioka A; Miyake M; Konishi S; Fujinani A; Tsujino G
Rinsho Ketsueki; 1982 Apr; 23(4):476-83. PubMed ID: 6957629
[No Abstract] [Full Text] [Related]
15. Aclarubicin in single agent and combined chemotherapy of acute myeloid leukaemias.
Mitrou PS
Eur J Haematol Suppl; 1987; 47():59-66. PubMed ID: 3471526
[No Abstract] [Full Text] [Related]
16. [Acute leukemia. Case material and therapeutic results].
Paolino W; Resegotti L; Rossi M; Infelise V; Degani GF
Minerva Med; 1975 May; 66(35):1642-52. PubMed ID: 1055305
[TBL] [Abstract][Full Text] [Related]
17. Phase I-II study of aclacinomycin for a treatment of acute myeloid leukemia.
Machover D; Gastiaburu J; Delgado M; Goldschmidt E; Hulhoven R; Misset JL; de Vassal F; Tapiero H; Dorval T; Ribaud P
Biomed Pharmacother; 1984; 38(7):328-31. PubMed ID: 6596962
[TBL] [Abstract][Full Text] [Related]
18. [Experience with using aclarubicin in the treatment of acute leukemia and blast crisis of chronic myeloid leukemia].
Savchenko VG; Isaev VG; Abakumov EM; Khoroshko ND; Turkina AG; Sokolov AN; Viadro MM; Navashin SM
Antibiot Khimioter; 1992 Jul; 37(7):47-9. PubMed ID: 1456812
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic trials of aclarubicin in previously treated acute leukemias and hematosarcomas].
Machover D; Goldschmidt E; Benavides M; Gastiaburu J; Vandenbulcke JM; Delgado M; Misset JL; Mathe G
Pathol Biol (Paris); 1987 Jan; 35(1):79-86. PubMed ID: 3550616
[TBL] [Abstract][Full Text] [Related]
20. Treatment of refractory acute leukemia with aclacinomycin-A.
Takahashi I; Hara M; Adachi T; Takaoka K; Sakano M; Lai M; Kohi F; Yorimitsu S; Tokioka M; Kitajima K; Kimura I; Sanada H
Acta Med Okayama; 1980 Nov; 34(5):349-54. PubMed ID: 6449134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]